Holtzman and Harlan Sprague-Dawley rats: Differences in DRL 72-sec performance and 8-hydroxy-di-propylamino tetralin-lnduced hypothermia

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 2, 1998, Pages 742-752

  Balcells Olivero, Mercedes ^a   Cousins, Michael S ^a   Seiden, Lewis S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; AMPHETAMINE; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; KETANSERIN; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; STRAIN DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BODY TEMPERATURE; CONDITIONING, OPERANT; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOTHERMIA; MALE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT SCHEDULE; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; SPECIES SPECIFICITY;

EID: 0032427637     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Berrettini WH, Ferraro TN, Goldin LR, Detera-Wadleigh SD, Choi H, Muniec D, Guroff JJ, Kazuba DM, Nnurnberger JI Jr, Hsieh WT, Hoehe MR and Gershon ES (1997) A linkage study of bipolar illness. Arch Gen Psychiatry 54:27-35.
2. Berrettini WH, Goldin LR, Gelernter J, Gejman PV, Gershon ES and Detera-Wadleigh S (1990) X-chromosome markers and manic-depressive illness. Rejection of linkage to Xq28 in nine bipolar pedigrees. Arch Gen Psychiatry 47:366-373.
3. Bizot JC, Thiebot MH, LeBihan C, Soubrie P (1988) Effects of imipramine-like drugs and serotonin uptake blockers on delay of reward in rats. Possible implication in the behavioural mechanism of action of antidepressants. J Pharmacol Exp Ther 246:1144-1151.
4. Cowen PJ, Power AC, Ware CJ and Anderson IM (1994) 5-H. T.1a receptor sensitivity in major depression: A neuroendocrine study with buspirone. Br J Psychiatry 164:372-379.
5. Dunn RT, Richards JB and Seiden LS (1993) Effects of salbutamol upon performance on an operant screen for antidepressants. Psychopharmacology 113:1-10.
6. Evenden JL and Ryan CN (1996) The pharmacology of impulsive behavior in rats: The effects of drugs on response choice with varying delays of reinforcement. Psychopharmacology 128:161-170.
7. Farfel GM and Seiden LS (1995) Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX. J Pharmacol Exp Ther 272:860-867.
8. Ferster CB and Skinner BF (1957) Schedules of Reinforcement. Appleton-Century-Crofts, New York.
9. File SE, Gonzalez LE and Andrews N (1996) Comparative study of pre- and postsynaptic 5-HT1A receptor modulation of anxiety in two ethological animal tests. J Neurosci 16:4810-4815.
10. Gonzalez LE, Andrews N and File SE (1996) 5-H. T.1A. and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Res 732:145-153.
11. Greenough WT, Mcdonald JW, Parnisari RM, Camel JE (1986) Environmental conditions modulate degeneration and new dendrite growth in the cerebellum of senescent rats. Brain Res 380:136-143.
12. Homyal-Zahrani SSA, Velazquez-Martinez DN, Lopez-Cabrera M, Bradshaw CM and Szabadi E (1996) Effects of desipramine and fluvoxamine on timing behaviour investigated with the fixed-interval peak procedure and the interval bisection task. Psychopharmacology 125:274-284.
13. Hulihan-Giblin BA, Park YD, Aulakh CS and Goldman D (1992) Regional analysis of 5-HT1A AND 5-HT2 receptors in the Fawn-Hooded rat. Neuropharmacology 31: 1095-1099.
14. Jolly DC, Richards JB and Seiden LS (1998) Serotonergic mediation of DRL 72-sec behavior: Receptor subtype involvement in a behavioral screen for antidepressant drugs. Biol Psychiatry, in press.
15. Lesch KP, Mayer S, Disselkamp-Tietze J, Hol A, Schoellnhammer G and Schulte HM (1990) Subsensitivity of the 5-hydroxytryptamine 1a (5-HT1a) receptor-mediated hypothermic response to ipsapirone in unipolar depression. Life Sci 46:1271-1277.
16. Li AA, Marek GJ, Hand TH and Seiden LS (1990) Antidepressant-like effects of trazodone on a behavioral screen are mediated by trazodone, not the metabolite m-chlorophenylpiperazine. Eur J Pharmacol 177:137-144.
17. Malberg JE and Seiden LS (1997) Administration of fenfluramine at different ambient temperatures produces different core temperature and 5-HT neurotoxicity profiles. Brain Res 765:101-107.
18. Marek GJ and Seiden LS (1988) Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule. J Pharmacol Exp Ther 244:650-658.
19. Marek GJ, LIAA and Seiden LS (1989a) Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior. J Pharmacol Exp Ther 250:60-71.
20. Marek GJ, LIAA and Seiden LS (1989b) Selective 5-hydroxytryptamine2 antagonists have antidepressant-like effects on differential-reinforcement-of-low-rate 72-second schedule. J Pharmacol Exp Ther 250:52-59.
21. Mcguire PS and Seiden LS (1980a) Differential effects of imipramine in rats as a function of DRL schedule value. Pharmacol Biochem Behav 13:691-694.
22. Mcguire PS and Seiden LS (1980b) The effects of tricyclic antidepressants on performance under a differential-reinforcement-of-low-rates schedule in rats. J Pharmacol Exp Ther 214:635-641.
23. Meltzer HY and Maes M (1995) Effects of ipsapirone on plasma cortisol and body temperature in major depression. Biol Psychiatry 38:450-457.
24. O'Donnell JM and Seiden LS (1982) Effects of monoamine oxidase inhibitors on performance during differential reinforcement of low response rate. Psychopharmacology (Berl) 78:214-218.
25. O'Donnell JM and Seiden LS (1983) Differential-reinforcement-of-low-rate 72-second schedule: Selective effects of antidepressant drugs. J Pharmacol Exp Ther 224: 80-88.
26. O'Donnell JM and Seiden LS (1984) Altered effects of desipramine on operant performance after 6-hydroxydopamine-induced depletion of brain dopamine or norepinephrine. J Pharmacol Exp Ther 229:629-635.
27. Overstreet DH and Rezvani AH (1996) Behavioral differences between two inbred strains of Fawn-Hooded rat: A model of serotonin dysfunction. Psychopharmacology 128:328-330.
28. Overstreet DH, Rezvani AH, Knapp DJ, Crews FT and Janowsky DS (1996) Further selection of rats lines differing in 5-HT-1A receptor sensitivity: behavioral and functional correlates. Psychiat Genet 6:107-117.
29. Pare WP and Kluczynski J (1997) Differences in the stress response of Wistar-Kyoto (WKY) rats from different vendors. Physiol Behav 62(3):643-648.
30. Richards JB, Sabol KE, Hand TH, Jolly DC, Marek GJ and Seiden LS (1994) Buspirone, gepirone, ipsapirone and zalospirone have unique effects on the differential-reinforcement-of-Iow-rate 72-second schedule when compared to 5-HTP and diazepam. Psychopharmacology 114:39-46.
31. Richards JB, Sabol KE and Seiden LS (1993a) Fluoxetine prevents the disruptive effects of fenfluramine on differential-reinforcement-of-low-rate 72-sec schedule performance. J Pharmacol Exp Ther 267:3, 1257-1258.
32. Richards JB, Sabol KE and Seiden LS (1993b) Drl interresponse-time distributions: Quantification by peak deviation analysis. J Exp Anal Behav 60:361-385.
33. Richards JB and Seiden LS (1991) A quantitative interresponse-time analysis of DHL performance differentiates similar effects of the antidepressant desipramine and the novel anxiolytic gepirone. J Exp Anal Behav 56:173-192.
34. Seiden LS, Dahms JL and Shaughnessy RA (1985) Behavioral screen for antidepressants: the effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule. Psychopharmacology (Berl) 86: 55-60.
35. Seiden LS, Marek G, O'Donnell JMLIA, Dunn R and Jolly D (1987) Role of noradrenergic and serotonergic systems in the screening of antidepressant drugs, in Progress in Catecholamine Research (Belmaker RH, Sandier M and Dahlstrom A, eds) pp 337-342, Alan R. Liss, Inc. New York.
36. Sidman M (1955) Technique for assessing the effects of drugs on timing behavior. Science 122:925.
37. Singh A and Lucki I (1993) Antidepressant-like activity of compounds with varying efficacy at 5-HT1A receptors. Neuropharmacology 32:331-340.
38. Snapper AG, Stephens KR, Cobez RI, Van Haaren F (1976) The SKED Software System: 0S8 and Time Share SKED, State Systems, Kalamazoo, MI.
39. Soubrie P (1989) 5-HT1A receptors: a bridge between anxiety and depression, in Behavioral Pharmacology of B-HT (Bevan ARCP and Archer T, eds) pp 337-352, Lawrence Erlbaum Associates, Hillsdale, NJ.
40. Stahl SM (1993) Serotonergic mechanisms and the new antidepressants [editorial]. [Review]. Psychol Med 23:281-285.
41. Sudakov SK, Borisova EV, Lyupina YV (1996) Influence of inheritance and fostering on sensitivity to effects of morphone on nociception and locomotor activity in two inbred rat strains. Neuropharmacology 35:1131-1134.
42. Sussman N (1994) The potential benefits of serotonin receptor-specific agents. [Review]. Journal of Clinical Psychiatry 55:(Suppl):45-51.
43. Wieland S and Lucki I (1990) Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test. Psychopharmacology (Berl) 101:497-504.
44. Winer BJ (1971) Statistical Principles in Experimental Design, McGraw-Hill, New York.